Health · 23 views
Link between liver fibrosis in MASLD, ASCVD varies by glycemic status
For patients with metabolic dysfunction-associated steatotic liver disease (MASLD), the association between liver fibrosis and atherosclerotic cardiovascular disease (ASCVD) varies with glycemic status, according to a study published in…
AI Summary
A recent study has found a link between liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and atherosclerotic cardiovascular disease (ASCVD). The relationship between liver fibrosis and ASCVD in MASLD patients is influenced by their glycemic status.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedCoverage Context
More from Health
Continue reading recent Health coverage
- Clinical guideline on radiation therapy for bladder cancer releasedContinue reading
- Ancestral diet-inspired pregnancy trial boosts growth in key fetal brain regionContinue reading
- The Letby inquiry report makes one thing crystal clear: too much NHS management is scandalously poor | Tom DolphinContinue reading
- Why some adults under 50 may develop early-onset cirrhosis from fatty liver diseaseContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow